服务不足人群中的炎症性肠病：实践中的教训。
Inflammatory bowel disease in underserved populations: lessons for practice.
机构信息
Division of GI & Liver Disease, Department of Medicine, Keck School of Medicine of USC, Los Angeles, California.
Department of Medicine, New York Presbyterian/Weill Cornell Medical Center, New York, New York.
出版信息
Curr Opin Gastroenterol. 2022 Jul 1;38(4):321-327. doi: 10.1097/MOG.0000000000000855.
PURPOSE OF REVIEW
The incidence of inflammatory bowel disease (IBD) is increasing in minority groups across the USA. There are racial and ethnic disparities in IBD care and outcomes that are rooted in historical injustice and inequities in the social determinants of health.
RECENT FINDINGS
Current literature has identified racial, ethnic and sociodemographic disparities in therapeutics and outcomes for IBD, including disease severity, morbidity and mortality.
SUMMARY
Strategies to achieve equity in IBD include tackling structural racism as a driver of health disparities and making actionable changes against multilevel barriers to care.
目的综述
在美国，少数民族群体中炎症性肠病（IBD）的发病率正在上升。IBD 的护理和结果存在种族和民族差异，其根源在于健康的社会决定因素中的历史不公正和不平等。
最近的发现
目前的文献已经确定了 IBD 治疗和结果中的种族、民族和社会人口统计学差异，包括疾病严重程度、发病率和死亡率。
总结
实现 IBD 公平的策略包括解决作为健康差异驱动因素的结构性种族主义，并针对护理的多层次障碍采取可行的改变。
Zotero 插件